Yoko Naito

Cell Cycle-Dependent Rho GTPase Activity Dynamically Regulates Cancer Cell Motility and Invasion In Vivo

Yoshinori Kagawa, Shinji Matsumoto, Yuji Kamioka et al. · PLoS ONE · 2013 · 96 citations · Full text

Cell Cycle, Cancer Biology, Tumor Biology +20

Gefitinib and Luteolin Cause Growth Arrest of Human Prostate Cancer PC-3 Cells via Inhibition of Cyclin G-Associated Kinase and Induction of miR-630

Minami A. Sakurai, Yuki Ozaki, Daisuke Okuzaki et al. · PLoS ONE · 2014 · 94 citations · Full text

Urology, Gak Expression, Medicine +13

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

Cell-cycle-controlled radiation therapy was effective for treating a murine malignant melanoma cell line in vitro and in vivo

Keisuke Otani, Yoko Naito, Yukako Sakaguchi et al. · Scientific Reports · 2016 · 50 citations · Full text

Interferon-α Acts on the S/G2/M Phases to Induce Apoptosis in the G1 Phase of an IFNAR2-expressing Hepatocellular Carcinoma Cell Line

Sakae Maeda, Hiroshi Wada, Yoko Naito et al. · Journal of Biological Chemistry · 2014 · 49 citations · Full text